Enable Lassa Research Programme Mid-term Workshop report

The Enable Lassa Research Programme is a prospective multi-site cohort study to estimate incidence of infection and disease due to Lassa fever virus, following 23,000 participants across five West African countries. To discuss the interim results of the Enable study ... Read more

CEPI exapnds partnership with The Brighton Collaboration

Safety Platform for Emergency Vaccines (SPEAC)

Renewed partnership will broaden the scope of SPEAC to deliver world-leading vaccine safety guidance & support for CEPI’s mission to compress development of new vaccines against pathogens with pandemic potential to 100 days Read more



Long COVID: Implications for Clinical Development

by Paul Oloo

This summary document focusses on Long COVID, also known as post-COVID syndrome or post-acute COVID-19, in the context of clinical development and vaccine efficacy trials. Long COVID is typically assessed ...